Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients

A RANDOMIZED PROSPECTIVE TRIAL OF ORAL ACYCLOVIR VS. ORAL GANCICLOVIR FOR CMV PROPHYLAXIS IN HIGH RISK KIDNEY TRANSPLANT RECIPIENTS

10.1097/00007890-199805131-00735 ◽

1998 ◽

Vol 65 (Supplement) ◽

pp. 263

Author(s):

S M Flechner ◽

K O'Malley ◽

R Fisher ◽

B Mastroianni ◽

D. Papajcik ◽

...

Keyword(s):

High Risk ◽

Kidney Transplant ◽

Prospective Trial ◽

Oral Ganciclovir ◽

Oral Acyclovir ◽

Transplant Recipients ◽

Randomized Prospective Trial ◽

Cmv Prophylaxis

A RANDOMIZED PROSPECTIVE TRIAL OF ORAL ACYCLOVIR VS. ORAL GANCICLOVIR FOR CMV PROPHYLAXIS IN HIGH RISK KIDNEY TRANSPLANT RECIPIENTS

10.1097/00007890-199806270-00758 ◽

1998 ◽

Vol 65 (12) ◽

pp. S187 ◽

Cited By ~ 3

Author(s):

S M Flechner ◽

K O'Malley ◽

R Fisher ◽

B Mastroianni ◽

D. Papajcik ◽

...

Keyword(s):

High Risk ◽

Kidney Transplant ◽

Prospective Trial ◽

Oral Ganciclovir ◽

Oral Acyclovir ◽

Transplant Recipients ◽

Randomized Prospective Trial ◽

Cmv Prophylaxis

Incidence of Major Adverse Cardiovascular Events and Cardiac Mortality in High-Risk Kidney-Only and Simultaneous Pancreas−Kidney Transplant Recipients

Kidney International Reports ◽

10.1016/j.ekir.2021.02.019 ◽

2021 ◽

Author(s):

Wai H. Lim ◽

Charmaine Lok ◽

S. Joseph Kim ◽

Greg Knoll ◽

Baiju Shah ◽

...

Keyword(s):

High Risk ◽

Kidney Transplant ◽

Cardiovascular Events ◽

Major Adverse Cardiovascular Events ◽

Cardiac Mortality ◽

Transplant Recipients ◽

Simultaneous Pancreas Kidney

Ramadan fast in kidney transplant recipients: a prospective comparative study

Transplantation Proceedings ◽

10.1016/j.transproceed.2003.08.072 ◽

2003 ◽

Vol 35 (7) ◽

pp. 2614-2616 ◽

Cited By ~ 12

Author(s):

T Said ◽

M.R.N Nampoory ◽

M.A Haleem ◽

M.P Nair ◽

K.V Johny ◽

...

Keyword(s):

Comparative Study ◽

Kidney Transplant ◽

Transplant Recipients ◽

Prospective Comparative Study

C3d-binding Donor-specific HLA Antibody Is Associated With a High Risk of Antibody-mediated Rejection and Graft Loss in Stable Kidney Transplant Recipients: A Single-center Cohort Study

Transplantation Proceedings ◽

10.1016/j.transproceed.2018.06.037 ◽

2018 ◽

Vol 50 (10) ◽

pp. 3452-3459 ◽

Cited By ~ 2

Author(s):

D.R. Lee ◽

B.C. Kim ◽

J.P. Kim ◽

I.G. Kim ◽

M.Y. Jeon

Keyword(s):

Cohort Study ◽

High Risk ◽

Kidney Transplant ◽

Graft Loss ◽

Transplant Recipients ◽

Single Center ◽

Antibody Mediated Rejection ◽

Hla Antibody

Pre-transplant soluble CD30 in combination with total DSA but not pre-transplant C1q-DSA predicts antibody-mediated graft loss in presensitized high-risk kidney transplant recipients

HLA ◽

10.1111/tan.12735 ◽

2016 ◽

Vol 87 (2) ◽

pp. 89-99 ◽

Cited By ~ 9

Author(s):

S. M. Schaefer ◽

C. Süsal ◽

G. Opelz ◽

B. Döhler ◽

L. E. Becker ◽

...

Keyword(s):

High Risk ◽

Kidney Transplant ◽

Graft Loss ◽

Transplant Recipients ◽

Soluble Cd30

Optimal Dose of Thymoglobulin for Induction Therapy in High Risk Kidney Transplant Recipients

The Journal of the Korean Society for Transplantation ◽

10.4285/jkstn.2016.30.2.82 ◽

2016 ◽

Vol 30 (2) ◽

pp. 82

Author(s):

Yaerim Kim ◽

Seong Sik Kang ◽

Woo Yeong Park ◽

Kyubok Jin ◽

Sung Bae Park ◽

...

Keyword(s):

High Risk ◽

Kidney Transplant ◽

Induction Therapy ◽

Optimal Dose ◽

Transplant Recipients ◽

Kidney Transplant Recipients

Universal prophylaxis with valganciclovir versus preemptive therapy in minimizing the risk of cytomegalovirus infection and disease in high-risk and intermediate-risk kidney transplant recipients: a single-center experience

Journal of The Egyptian Society of Nephrology and Transplantation ◽

10.4103/jesnt.jesnt_18_19 ◽

2019 ◽

Vol 19 (3) ◽

pp. 68

Author(s):

MuhammadTassaduq Khan ◽

Sabahat Sarfaraz ◽

Rashid bin Hamid ◽

Naranjan Lal ◽

Shanila Javaid ◽

...

Keyword(s):

High Risk ◽

Kidney Transplant ◽

Cytomegalovirus Infection ◽

Preemptive Therapy ◽

Intermediate Risk ◽

Transplant Recipients ◽

Single Center ◽

Single Center Experience

The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis

10.1097/tp.0000000000003124 ◽

2020 ◽

Vol 104 (10) ◽

pp. 2139-2147 ◽

Cited By ~ 2

Author(s):

Mayara I. de Paula ◽

Sunjae Bae ◽

Ashton A. Shaffer ◽

Jacqueline Garonzik-Wang ◽

Claudia R. Felipe ◽

...

Keyword(s):

High Risk ◽

Kidney Transplant ◽

Antithymocyte Globulin ◽

Transplant Recipients ◽

Cmv Infection ◽

Pharmacological Prophylaxis

ZENAPAX VERSUS OKT-3 PROPHYLAXIS IN IMMUNOLOGICALLY HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS.

10.1097/00007890-200004271-00174 ◽

2000 ◽

Vol 69 (Supplement) ◽

pp. S158 ◽

Cited By ~ 3

Author(s):

Jiri Lacha ◽

Marcela Simova ◽

Ladislava Noskova ◽

Vladimir Teplan ◽

Stefan Vitko

Keyword(s):

High Risk ◽

Kidney Transplant ◽

Transplant Recipients ◽

Kidney Transplant Recipients